Antiplatelet Therapy
Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis
... Individual antiplatelet agents reduce recurrent events by 15%-20%, as seen with aspirin and dipyridamole [7,8] and from indirect comparisons for clopidogrel, triflusal and ...oral antiplatelet agents is ...
14
TRIPLE ANTIPLATELET THERAPY AND INCIDANCE OF DRUG RESISTANCE
... to antiplatelet or non-responsiveness to therapy is associated with acute coronary syndrome or repeat ...triple antiplatelet therapy group observed with myocardial infarction and ...triple ...
9
Duration of dual antiplatelet therapy after coronary stent insertion
... dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal ...
7
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
... our antiplatelet therapy strategies are largely based upon overall and subgroup findings in large ...tailored therapy based on platelet function assays (PFAs) and perhaps genotyping will likely ...
15
Prevalence of antiplatelet therapy in patients with diabetes
... receiving antiplatelet therapy despite consensus guidelines? First of all, prescrib- ers may feel there is some ambiguity regarding the role of aspirin in CVD primary prevention for patients with dia- ...of ...
7
Newer agents in antiplatelet therapy: a review
... new antiplatelet therapies exists as the risk for MI, stroke, and death, remain a persistent problem for individuals suf- fering from cardiovascular ...in antiplatelet therapy, the risk of bleeding ...
10
Dual Antiplatelet Therapy in Cardiology: Novel Guidelines
... dual antiplatelet therapy (DAPT) with the COX1/2 inhibitor aspirin and the P 2 Y 12 inhibitor clopidogrel was found to be more effective than oral anticoagulation (OAC) in reducing the risk of recurring ...
11
DENTAL MANAGEMENT OF PATIENTS ON ANTIPLATELET THERAPY: LITERATURE UPDATE
... aspirin therapy, thus creating a prothrombotic state which may ultimately cause fatal thromboembolic ...aspirin therapy [31-35]. One study pointed out that suspending aspirin therapy resulted in a ...
6
Role of antiplatelet therapy in ischemic stroke – a review
... Stroke is one of the leading cause of disability and death. Stroke is of two types ,ischemic stroke and hemorrhagic stroke. Of the two major forms of stroke, ischemic stroke is the most common accounting upto 85% of ...
6
Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
... of therapy at steady state, although the IPA levels did not become statistically significantly different until 72 ...of antiplatelet therapy in patients with stable ...
23
Dual antiplatelet therapy for secondary stroke prevention
... of therapy, which agent should be continued when stepping down to single antiplatelet therapy (SAPT), and who should receive gastroprotec- ...of therapy are also ...
6
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
... dual antiplatelet therapy with ASA and thienopyridines (ticlopidine or clopido- grel) is limited by the variability in the antiplatelet response ...to antiplatelet therapy to an ...
12
Antiplatelet therapy following ischaemic stroke: continue or change pre existing therapy?
... Introduction: Antiplatelet therapy is routinely prescribed early after ischaemic ...taking antiplatelet therapy and it is unknown whether these patients should continue the same ...
18
Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
... (CAL). Antiplatelet therapy is a routine component of Kawasaki disease treatment ...the antiplatelet effect of aspirin because of the individual biological variability of antiplatelet effect ...
10
The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
... “triple antiplatelet therapy”, “TAPT”, “dual anti- platelet therapy”, “DAPT”, “acute myocardial infarction or AMI”, “acute coronary syndrome or ACS”, “chronic total occlusion”, “left main”, ...
14
Dual antiplatelet therapy for secondary prevention of coronary artery disease
... The concept of DAPT will be challenged during the next years by several ongoing RCTs that will explore novel strategies using P2Y 12 receptor inhibitors, clopido- grel (STOPDAPT-2 (NCT02619760), SMART-CHOICE ...
16
Single versus Dual Antiplatelet Therapy after CABG Surgery
... optimal antiplatelet therapy regimen in the early post-operative CABG period is not well ...dual antiplatelet therapy had better outcomes in those status-post CABG ...combination ...
5
Proteinase-activated receptors (PARs) as targets for antiplatelet therapy
... Following many years of development, the first PAR1 competitive antagonist, vorapaxar (Zontivity), was approved for clinical use in the United States as an adjunctive antiplatelet therapy in the treatment ...
12
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
... The decision to extend anticoagulant treatment (be- yond the first 3 ~ 6 months) is dependent on the patient and physician’s “trade-off” acceptability of bleeding risk and recurrence risk [27, 28, 30]. For patients with ...
11
Sarpogrelate Based Triple Antiplatelet Therapy Improved Left Ventricular Systolic Function in Acute Myocardial Infarction: Retrospective Study
... of therapy due to dyspnea was infrequent in the PLATO trial, it occurred significantly more commonly in patients treated with ticagrelor than in those re- ceiving ...
9